Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.9%

2 terminated out of 34 trials

Success Rate

86.7%

+0.2% vs benchmark

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed with results

Key Signals

5 with results87% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (10)
P 1 (6)
P 2 (6)
P 3 (1)
P 4 (1)

Trial Status

Completed13
Recruiting9
Unknown5
Terminated2
Withdrawn2
Active Not Recruiting2

Trial Success Rate

86.7%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT05611034Phase 1RecruitingPrimary

In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung

NCT07499674Phase 3Recruiting

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

NCT02226276Not ApplicableActive Not Recruiting

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

NCT06651658Not ApplicableRecruiting

Oxford Pleural Embolisation Trial

NCT04940936Not ApplicableRecruiting

Shared Decision Making on Radiation Dose for Lung Malignancies

NCT07112989Recruiting

Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors

NCT05755672Recruiting

On-treatment Biomarkers in Metastatic Colorectal Cancer for Life

NCT04200417Phase 1CompletedPrimary

Chemoembolization for Lung Tumors

NCT02496585Phase 2Completed

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

NCT06145048Phase 2Completed

Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.

NCT01586104Not ApplicableCompleted

Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

NCT03944798Not ApplicableActive Not Recruiting

Surveillance AFter Extremity Tumor surgerY

NCT01706432Completed

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

NCT02107755Phase 2Completed

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

NCT06321640Recruiting

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

NCT03108677UnknownPrimary

Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma

NCT03984019Not ApplicableTerminated

Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis

NCT05816902Completed

AI Prediction Model and Risk Stratification for Lung Metastasis in Colorectal Cancer

NCT05808790Not ApplicableNot Yet RecruitingPrimary

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy

NCT04455438Not ApplicableUnknown

SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions

Scroll to load more

Research Network

Activity Timeline